APREMILAST

APREMILAST was reported 146435 times

APREMILAST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 437 0.6542
1 HEPATIC ENZYME 82 0.5503
2 C-REACTIVE PROTEIN 509 0.5491
3 LUPUS VULGARIS 643 0.5103
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1005 0.5017
5 RHEUMATIC FEVER 2214 0.4962
6 SWOLLEN JOINT COUNT INCREASED 1574 0.4931
7 GRIP STRENGTH 112 0.4891
8 SWOLLEN JOINT COUNT 121 0.4840
9 RED BLOOD CELL SEDIMENTATION RATE 130 0.4659
10 FACET JOINT SYNDROME 1446 0.4437
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 811 0.3910
12 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 213 0.3797
13 RETINITIS 643 0.3719
14 DISLOCATION OF VERTEBRA 818 0.3583
15 X-RAY ABNORMAL 613 0.3425
16 HYPOCHOLESTEROLAEMIA 113 0.3201
17 RHEUMATOID FACTOR POSITIVE 1793 0.3101
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2160 0.3012
19 DUODENAL ULCER PERFORATION 2235 0.3002
20 SERONEGATIVE ARTHRITIS 309 0.2696
21 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 28 0.2667
22 PERIPHERAL VENOUS DISEASE 1061 0.2595
23 C-REACTIVE PROTEIN ABNORMAL 1611 0.2509
24 BONE EROSION 869 0.2455
25 ENTHESOPATHY 360 0.2300
26 TENDER JOINT COUNT 19 0.2262
27 HELICOBACTER INFECTION 2194 0.2133
28 PSORIATIC ARTHROPATHY 8315 0.2047
29 FOLLICULITIS 2146 0.2044
30 MUSCLE INJURY 1652 0.1992
31 HAND DEFORMITY 2502 0.1906
32 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1191 0.1832
33 PEMPHIGUS 2284 0.1825
34 BREAST CANCER STAGE III 1131 0.1745
35 GRANULOMA SKIN 143 0.1742
36 SYNOVITIS 3070 0.1701
37 ONYCHOMADESIS 697 0.1659
38 OVERLAP SYNDROME 115 0.1643
39 PSORIASIS 20666 0.1581
40 REBOUND PSORIASIS 89 0.1532
41 GRIP STRENGTH DECREASED 1324 0.1503
42 HYPERCHOLESTEROLAEMIA 1437 0.1487
43 LIP DRY 1337 0.1471
44 PORPHYRIA ACUTE 203 0.1415
45 PERICARDITIS 2316 0.1377
46 BLEPHAROSPASM 850 0.1349
47 WOUND INFECTION 1454 0.1326
48 JOINT RANGE OF MOTION DECREASED 1719 0.1280
49 BURSITIS 1495 0.1231
50 TENOSYNOVITIS 336 0.1217
51 GLOSSODYNIA 2572 0.1148
52 BLOOD PARATHYROID HORMONE DECREASED 168 0.1133
53 ONYCHOMYCOSIS 492 0.1120
54 DRUG TOLERANCE DECREASED 309 0.1099
55 PALMOPLANTAR PUSTULOSIS 57 0.1078
56 AUTOIMMUNE DISORDER 1040 0.1066
57 LIVE BIRTH 889 0.1062
58 BODY TINEA 59 0.1054
59 IRRITABLE BOWEL SYNDROME 2144 0.0999
60 DEATH NEONATAL 137 0.0984
61 FIBROMYALGIA 2326 0.0956
62 EXOSTOSIS 855 0.0935
63 WOUND 2612 0.0934
64 PUSTULAR PSORIASIS 307 0.0893
65 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
66 THERAPY NON-RESPONDER 3932 0.0874
67 NAIL DISORDER 760 0.0868
68 DACTYLITIS 85 0.0866
69 TENSION HEADACHE 368 0.0855
70 INFUSION SITE REACTION 252 0.0843
71 SCIATICA 1333 0.0835
72 RED BLOOD CELL SEDIMENTATION RATE INCREASED 905 0.0817
73 FINGER DEFORMITY 371 0.0765
74 SYSTEMIC LUPUS ERYTHEMATOSUS 2678 0.0754
75 TYPE 2 DIABETES MELLITUS 2532 0.0751
76 LIVER INJURY 1796 0.0731
77 JOINT DISLOCATION 753 0.0712
78 PANNICULITIS 171 0.0706
79 PRODUCT DOSE OMISSION 4594 0.0703
80 LUPUS-LIKE SYNDROME 631 0.0695
81 OBESITY 1054 0.0661
82 WALKING AID USER 434 0.0658
83 GENERALISED PUSTULAR PSORIASIS 19 0.0655
84 FOOT DEFORMITY 710 0.0640
85 JOINT ANKYLOSIS 36 0.0634
86 IMPAIRED HEALING 2065 0.0628
87 BACK INJURY 679 0.0624
88 RHEUMATOID NODULE 170 0.0617
89 CONTRAINDICATED PRODUCT ADMINISTERED 1854 0.0612
90 THERAPEUTIC PRODUCT EFFECT DECREASED 2686 0.0599
91 PRODUCT LABEL CONFUSION 346 0.0593
92 LOWER LIMB FRACTURE 1100 0.0572
93 SPONDYLITIS 205 0.0563
94 BREAST CANCER STAGE II 462 0.0555
95 ARTHROPATHY 3052 0.0549
96 HIP ARTHROPLASTY 766 0.0500
97 BLOOD CHOLESTEROL INCREASED 2326 0.0498
98 ABDOMINAL DISCOMFORT 8337 0.0497
99 RHEUMATOID LUNG 47 0.0492
100 C-REACTIVE PROTEIN INCREASED 1772 0.0487
101 GAIT INABILITY 1626 0.0486
102 PULMONARY FIBROSIS 926 0.0482
103 MATERNAL EXPOSURE TIMING UNSPECIFIED 175 0.0465
104 HEPATIC CIRRHOSIS 866 0.0460
105 RASH VESICULAR 222 0.0459
106 FREQUENT BOWEL MOVEMENTS 1223 0.0452
107 PRESCRIBED OVERDOSE 874 0.0451
108 OSTEOARTHRITIS 1913 0.0451
109 ADVERSE REACTION 588 0.0443
110 FAECES SOFT 313 0.0430
111 LIVER FUNCTION TEST INCREASED 908 0.0423
112 COELIAC DISEASE 412 0.0420
113 INFUSION RELATED REACTION 2722 0.0410
114 PRODUCT ADMINISTRATION INTERRUPTED 322 0.0410
115 DISCOMFORT 2460 0.0403
116 BLISTER 2248 0.0400
117 HEPATIC ENZYME INCREASED 2711 0.0397
118 NIGHT SWEATS 1280 0.0397
119 PRODUCT SUPPLY ISSUE 282 0.0395
120 TASTE DISORDER 798 0.0393
121 GASTRIC DISORDER 1348 0.0392
122 JOINT STIFFNESS 1030 0.0392
123 DIARRHOEA 24755 0.0383
124 INFLAMMATION 1958 0.0379
125 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 87 0.0377
126 ADVERSE DRUG REACTION 3374 0.0375
127 MOBILITY DECREASED 2671 0.0371
128 KNEE ARTHROPLASTY 770 0.0365
129 PRESCRIBED UNDERDOSE 713 0.0357
130 INHIBITORY DRUG INTERACTION 56 0.0354
131 LOWER RESPIRATORY TRACT INFECTION 1609 0.0353
132 NORMAL NEWBORN 192 0.0353
133 BONE CYST 33 0.0352
134 UPPER RESPIRATORY TRACT INFECTION 1614 0.0349
135 WHEEZING 2036 0.0343
136 GASTROINTESTINAL DISORDER 3065 0.0342
137 TONGUE DISORDER 246 0.0340
138 STOMATITIS 2055 0.0338
139 MUSCULOSKELETAL STIFFNESS 2908 0.0332
140 SPINAL FUSION SURGERY 132 0.0325
141 ROAD TRAFFIC ACCIDENT 1357 0.0324
142 CUTANEOUS SYMPTOM 22 0.0322
143 TREATMENT FAILURE 2666 0.0321
144 DRUG INTOLERANCE 3108 0.0321
145 JOINT DESTRUCTION 50 0.0321
146 ULCER HAEMORRHAGE 216 0.0319
147 SKIN NECROSIS 164 0.0316
148 NAIL PSORIASIS 19 0.0307
149 DRUG TOLERANCE 154 0.0304
150 RHEUMATOID ARTHRITIS 3437 0.0302
151 EAR INFECTION 805 0.0302
152 INJURY 2119 0.0301
153 INFECTION SUSCEPTIBILITY INCREASED 65 0.0297
154 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2059 0.0289
155 JOINT SWELLING 3468 0.0287
156 HEADACHE 18012 0.0287
157 SLEEP DISORDER 2027 0.0287
158 SWELLING 2660 0.0284
159 CONGENITAL ANOMALY 219 0.0283
160 NAUSEA 22292 0.0281
161 DRUG-INDUCED LIVER INJURY 873 0.0278
162 LUNG DISORDER 1340 0.0273
163 MIGRAINE 2559 0.0268
164 ILL-DEFINED DISORDER 1628 0.0268
165 EPILEPSY 805 0.0263
166 CUTANEOUS T-CELL LYMPHOMA 33 0.0262
167 DYSPEPSIA 2553 0.0259
168 PREGNANCY 517 0.0258
169 GENERAL SYMPTOM 193 0.0257
170 GENERAL PHYSICAL HEALTH DETERIORATION 2958 0.0255
171 DISABILITY 502 0.0254
172 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1218 0.0253
173 LIVER DISORDER 1124 0.0253
174 MUSCULOSKELETAL PAIN 1321 0.0252
175 MUSCLE SWELLING 23 0.0250
176 LICHEN PLANUS 58 0.0250
177 SINUSITIS 2541 0.0248
178 DEPRESSION 5640 0.0248
179 MYOSITIS 218 0.0243
180 ABDOMINAL PAIN UPPER 4960 0.0241
181 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 57 0.0240
182 LATENT TUBERCULOSIS 49 0.0234
183 OEDEMA 1264 0.0233
184 DELIRIUM 808 0.0233
185 ERYTHRODERMIC PSORIASIS 19 0.0231
186 SINUS HEADACHE 137 0.0230
187 BACK DISORDER 364 0.0224
188 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 381 0.0222
189 GRANULOMA 76 0.0219
190 DRY MOUTH 1773 0.0218
191 MATERNAL EXPOSURE DURING PREGNANCY 1942 0.0218
192 EYE INJURY 66 0.0217
193 SKIN PLAQUE 180 0.0213
194 INFECTION 3051 0.0211
195 THERAPEUTIC RESPONSE DECREASED 1262 0.0208
196 MULTIPLE ALLERGIES 163 0.0208
197 EAR PAIN 401 0.0206
198 MACULE 57 0.0205
199 OSTEOPOROSIS 832 0.0202
200 ARTHRITIS 1591 0.0202
201 TENDONITIS 313 0.0202
202 GASTROOESOPHAGEAL REFLUX DISEASE 1566 0.0194
203 HYPOAESTHESIA 2847 0.0190
204 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 320 0.0188
205 NASOPHARYNGITIS 3412 0.0185
206 RESPIRATORY DISORDER 552 0.0184
207 PERIPHERAL SWELLING 2823 0.0183
208 WEIGHT DECREASED 5094 0.0182
209 SACROILIITIS 34 0.0180
210 INTENTIONAL PRODUCT USE ISSUE 1575 0.0180
211 SEBORRHOEIC KERATOSIS 26 0.0179
212 ALOPECIA 3383 0.0172
213 PRURITUS ALLERGIC 20 0.0171
214 OSTEOLYSIS 35 0.0171
215 DECREASED APPETITE 3968 0.0171
216 PRODUCT DOSE OMISSION ISSUE 4920 0.0167
217 DEPRESSION SUICIDAL 57 0.0165
218 BOWEL MOVEMENT IRREGULARITY 126 0.0164
219 HYPERSENSITIVITY 3051 0.0164
220 HEPATIC FIBROSIS 56 0.0163
221 EXPOSURE DURING PREGNANCY 1000 0.0161
222 MEMORY IMPAIRMENT 2207 0.0160
223 ADVERSE EVENT 1477 0.0160
224 COCCIDIOIDOMYCOSIS 19 0.0159
225 CONTUSION 1531 0.0159
226 NECK PAIN 887 0.0159
227 DANDRUFF 35 0.0158
228 RASH 6888 0.0158
229 ARTHRALGIA 6531 0.0157
230 SKIN INJURY 52 0.0157
231 FEAR OF INJECTION 111 0.0155
232 HYPERTENSION 3242 0.0153
233 DRUG DOSE OMISSION 2500 0.0151
234 URTICARIA 2531 0.0151
235 JOINT ARTHROPLASTY 27 0.0151
236 HEPATITIS 383 0.0150
237 ULCER 237 0.0149
238 HYPERCALCAEMIA 183 0.0148
239 NEOPLASM SKIN 23 0.0148
240 BASAL CELL CARCINOMA 230 0.0147
241 MOOD ALTERED 402 0.0147
242 THERAPY INTERRUPTED 1046 0.0146
243 DEPRESSIVE SYMPTOM 51 0.0145
244 GLUCOSE TOLERANCE IMPAIRED 85 0.0144
245 VOMITING 6639 0.0141
246 DRUG EFFECT DECREASED 760 0.0141
247 ONYCHOLYSIS 22 0.0141
248 POLYARTHRITIS 74 0.0140
249 AMNESIA 905 0.0139
250 EPIGASTRIC DISCOMFORT 54 0.0138
251 THERAPY PARTIAL RESPONDER 211 0.0135
252 SENSITIVITY TO WEATHER CHANGE 71 0.0135
253 BRONCHITIS 990 0.0134
254 VIRAL UPPER RESPIRATORY TRACT INFECTION 63 0.0132
255 CONDITION AGGRAVATED 3914 0.0129
256 SKIN DISORDER 428 0.0128
257 INSOMNIA 3411 0.0128
258 INFLAMMATORY BOWEL DISEASE 125 0.0128
259 UNEVALUABLE EVENT 962 0.0127
260 COLONOSCOPY 28 0.0127
261 DEFAECATION URGENCY 89 0.0127
262 MUSCLE SPASMS 2312 0.0126
263 CONFUSIONAL STATE 2032 0.0126
264 UTERINE DISORDER 29 0.0124
265 SKIN HAEMORRHAGE 182 0.0123
266 GASTROENTERITIS VIRAL 221 0.0122
267 COMPLEX REGIONAL PAIN SYNDROME 18 0.0122
268 PAPULE 85 0.0121
269 SKIN FISSURES 234 0.0120
270 HYPERTRANSAMINASAEMIA 83 0.0119
271 DRUG ERUPTION 211 0.0119
272 DRUG INEFFECTIVE 15674 0.0119
273 NO THERAPEUTIC RESPONSE 145 0.0119
274 CONTRAINDICATION TO MEDICAL TREATMENT 18 0.0118
275 RASH PRURITIC 638 0.0118
276 WEIGHT FLUCTUATION 123 0.0117
277 ASTHMA 1321 0.0117
278 MUSCULAR WEAKNESS 1322 0.0116
279 INFECTIOUS MONONUCLEOSIS 26 0.0116
280 PHARYNGITIS STREPTOCOCCAL 125 0.0115
281 PAIN 7045 0.0115
282 PRURITUS 4403 0.0114
283 MUSCULOSKELETAL DISORDER 217 0.0114
284 UPPER RESPIRATORY TRACT CONGESTION 33 0.0114
285 FLATULENCE 645 0.0114
286 SKIN ATROPHY 65 0.0113
287 DERMATITIS PSORIASIFORM 23 0.0112
288 EXPOSURE TO SARS-COV-2 19 0.0112
289 ESSENTIAL HYPERTENSION 20 0.0109
290 PARANASAL SINUS DISCOMFORT 41 0.0108
291 MALAISE 4726 0.0108
292 RESPIRATORY TRACT INFECTION 280 0.0107
293 SKIN ULCER 276 0.0107
294 SUSPECTED OFF LABEL USE 48 0.0106
295 WEIGHT INCREASED 2362 0.0105
296 IMMUNE SYSTEM DISORDER 139 0.0105
297 SINUS DISORDER 208 0.0105
298 DRUG EFFECT INCOMPLETE 381 0.0105
299 ABDOMINAL DISTENSION 1091 0.0104
300 PAIN IN EXTREMITY 3051 0.0103
301 DRUG EFFECT LESS THAN EXPECTED 153 0.0103
302 SQUAMOUS CELL CARCINOMA OF SKIN 62 0.0103
303 JOINT LOCK 29 0.0102
304 RESPIRATORY SYMPTOM 29 0.0102
305 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 27 0.0101
306 SHOULDER OPERATION 43 0.0100
307 SKIN DISCOMFORT 27 0.0100
308 JOINT INJURY 213 0.0100
309 AFFECTIVE DISORDER 78 0.0099
310 MOTION SICKNESS 19 0.0098
311 THERAPY CESSATION 498 0.0097
312 NEGATIVE THOUGHTS 28 0.0095
313 SKIN PAPILLOMA 38 0.0095
314 SEASONAL ALLERGY 134 0.0095
315 PRODUCT USE ISSUE 1771 0.0094
316 RED CELL DISTRIBUTION WIDTH INCREASED 39 0.0094
317 GASTROINTESTINAL PAIN 103 0.0094
318 ONYCHOCLASIS 64 0.0093
319 EAR CONGESTION 25 0.0092
320 GOUT 165 0.0092
321 INFLAMMATORY MARKER INCREASED 45 0.0091
322 SPINAL DISORDER 85 0.0090
323 RHINORRHOEA 575 0.0089
324 ACTINIC KERATOSIS 23 0.0089
325 SPINAL OPERATION 109 0.0088
326 INFLUENZA 975 0.0087
327 LYME DISEASE 29 0.0087
328 VOMITING PROJECTILE 25 0.0086
329 INTENTIONAL PRODUCT MISUSE 755 0.0086
330 MIDDLE EAR EFFUSION 19 0.0086
331 LOCALISED INFECTION 208 0.0086
332 FOOD POISONING 46 0.0086
333 PIGMENTATION DISORDER 53 0.0086
334 SKIN LESION 235 0.0086
335 MOOD SWINGS 273 0.0086
336 PARAESTHESIA 1345 0.0085
337 VITILIGO 20 0.0085
338 CHEST PAIN 1579 0.0085
339 DIVERTICULITIS 236 0.0085
340 NASAL CONGESTION 500 0.0085
341 GASTROINTESTINAL INFECTION 76 0.0085
342 EXFOLIATIVE RASH 22 0.0083
343 THERAPEUTIC PRODUCT EFFECT DELAYED 38 0.0083
344 RASH MACULAR 290 0.0083
345 MENISCUS INJURY 51 0.0083
346 FINE MOTOR SKILL DYSFUNCTION 24 0.0083
347 IMMUNOSUPPRESSION 73 0.0083
348 GASTROINTESTINAL SOUNDS ABNORMAL 41 0.0083
349 NEPHROLITHIASIS 378 0.0082
350 GALLBLADDER DISORDER 147 0.0082
351 PNEUMONIA 2661 0.0082
352 TOOTH ABSCESS 83 0.0081
353 FATIGUE 6327 0.0081
354 ABDOMINAL PAIN 1889 0.0081
355 HERNIA REPAIR 21 0.0081
356 FEELING JITTERY 154 0.0081
357 DEPRESSED MOOD 425 0.0080
358 PUSTULE 19 0.0080
359 POOR QUALITY SLEEP 172 0.0080
360 SINUS CONGESTION 107 0.0079
361 IMMUNODEFICIENCY 118 0.0079
362 LABORATORY TEST ABNORMAL 232 0.0079
363 JOINT EFFUSION 54 0.0078
364 ARTHROPOD BITE 58 0.0078
365 CELLULITIS 394 0.0078
366 PURPURA 69 0.0078
367 FOOT OPERATION 38 0.0077
368 SCAB 87 0.0076
369 OEDEMA PERIPHERAL 929 0.0076
370 ARTHRITIS BACTERIAL 31 0.0075
371 GAIT DISTURBANCE 1442 0.0075
372 MUSCLE SPASTICITY 92 0.0075
373 DERMATITIS EXFOLIATIVE GENERALISED 26 0.0075
374 INTRACRANIAL ANEURYSM 30 0.0075
375 ANXIETY 2105 0.0074
376 MALIGNANT MELANOMA 99 0.0074
377 STREPTOCOCCAL INFECTION 41 0.0074
378 SYMPTOM RECURRENCE 44 0.0073
379 SKIN INFECTION 82 0.0073
380 SUICIDAL IDEATION 669 0.0073
381 ROSACEA 34 0.0073
382 INJECTION SITE REACTION 501 0.0073
383 IMPAIRED QUALITY OF LIFE 104 0.0072
384 FUNCTIONAL GASTROINTESTINAL DISORDER 25 0.0072
385 ORAL DISORDER 53 0.0072
386 VISUAL IMPAIRMENT 893 0.0072
387 RECTAL HAEMORRHAGE 309 0.0072
388 BLOOD PRESSURE SYSTOLIC INCREASED 140 0.0072
389 MUSCLE STRAIN 62 0.0072
390 UPPER-AIRWAY COUGH SYNDROME 59 0.0072
391 DIZZINESS 3561 0.0071
392 TOOTH INFECTION 94 0.0071
393 SKIN HYPERTROPHY 20 0.0071
394 KNEE OPERATION 70 0.0071
395 ARTHRITIS INFECTIVE 33 0.0071
396 PRODUCT USE IN UNAPPROVED INDICATION 1758 0.0071
397 B-CELL LYMPHOMA 24 0.0071
398 RESPIRATORY TRACT CONGESTION 112 0.0070
399 VARICES OESOPHAGEAL 21 0.0069
400 SYNOVIAL CYST 32 0.0069
401 RETCHING 147 0.0069
402 HEPATIC STEATOSIS 127 0.0068
403 FURUNCLE 54 0.0068
404 GASTRIC INFECTION 26 0.0068
405 HERPES ZOSTER 390 0.0068
406 MEDICATION ERROR 377 0.0068
407 WHITE BLOOD CELL COUNT INCREASED 260 0.0068
408 SKIN EXFOLIATION 571 0.0068
409 PANCREATITIS 357 0.0067
410 INTENTIONAL DOSE OMISSION 192 0.0067
411 SARS-COV-2 TEST POSITIVE 88 0.0067
412 MELANOCYTIC NAEVUS 29 0.0066
413 TENDON DISORDER 43 0.0066
414 NEOPLASM MALIGNANT 440 0.0066
415 BACK PAIN 1527 0.0066
416 RASH GENERALISED 170 0.0066
417 SKIN CANCER 141 0.0065
418 INTERVERTEBRAL DISC DEGENERATION 60 0.0065
419 CARDIAC OPERATION 55 0.0064
420 SKIN DISCOLOURATION 294 0.0064
421 SKIN REACTION 90 0.0064
422 FOOT FRACTURE 121 0.0064
423 OSTEOMYELITIS 115 0.0063
424 TENDON PAIN 48 0.0063
425 FEELING HOT 388 0.0063
426 CONCUSSION 49 0.0063
427 DECREASED INTEREST 37 0.0063
428 COVID-19 1096 0.0062
429 EAR DISCOMFORT 64 0.0062
430 LYMPHOMA 96 0.0062
431 ASTHENIA 2332 0.0062
432 OFF LABEL USE 5427 0.0062
433 VARICOSE VEIN 32 0.0062
434 SQUAMOUS CELL CARCINOMA 58 0.0062
435 GENERALISED ERYTHEMA 35 0.0061
436 ORAL HERPES 120 0.0061
437 SPINAL PAIN 72 0.0061
438 INCORRECT DOSAGE ADMINISTERED 30 0.0061
439 CHRONIC SINUSITIS 23 0.0061
440 PYREXIA 2120 0.0061
441 LIGAMENT RUPTURE 27 0.0061
442 HIP SURGERY 33 0.0061
443 FAECES DISCOLOURED 132 0.0061
444 COLITIS ULCERATIVE 272 0.0061
445 LIMB OPERATION 29 0.0060
446 ERUCTATION 116 0.0060
447 CONCOMITANT DISEASE AGGRAVATED 37 0.0060
448 PAROSMIA 45 0.0060
449 OVERWEIGHT 32 0.0060
450 KIDNEY INFECTION 116 0.0059
451 RASH PUSTULAR 43 0.0059
452 UVEITIS 80 0.0059
453 UNDERDOSE 430 0.0059
454 ANTINUCLEAR ANTIBODY POSITIVE 19 0.0058
455 BREAST CANCER STAGE I 54 0.0058
456 FUNGAL INFECTION 194 0.0058
457 CHEMOTHERAPY 22 0.0058
458 URINE ODOUR ABNORMAL 34 0.0058
459 HYPERLIPIDAEMIA 69 0.0058
460 PARANASAL SINUS HYPERSECRETION 22 0.0058
461 SURGERY 337 0.0057
462 FEEDING DISORDER 116 0.0057
463 ILLNESS 589 0.0057
464 COLITIS MICROSCOPIC 27 0.0057
465 ANKYLOSING SPONDYLITIS 75 0.0057
466 GALLBLADDER OPERATION 23 0.0057
467 LOSS OF THERAPEUTIC RESPONSE 18 0.0056
468 FLUID RETENTION 287 0.0056
469 CUSHINGOID 18 0.0056
470 CORONAVIRUS INFECTION 37 0.0056
471 THERAPY CHANGE 55 0.0056
472 HEAD DISCOMFORT 99 0.0056
473 SPINAL STENOSIS 23 0.0056
474 HORDEOLUM 24 0.0055
475 DECREASED IMMUNE RESPONSIVENESS 54 0.0055
476 ABNORMAL FAECES 45 0.0055
477 EAR DISORDER 25 0.0055
478 FUNGAL SKIN INFECTION 22 0.0054
479 INCREASED TENDENCY TO BRUISE 50 0.0054
480 PEMPHIGOID 41 0.0054
481 CARPAL TUNNEL SYNDROME 76 0.0054
482 UPPER LIMB FRACTURE 108 0.0054
483 TRIGGER FINGER 22 0.0054
484 IMPAIRED WORK ABILITY 114 0.0053
485 EYE INFECTION 60 0.0053
486 MENSTRUAL DISORDER 44 0.0053
487 SCRATCH 56 0.0053
488 QUALITY OF LIFE DECREASED 71 0.0053
489 COUGH 1482 0.0053
490 TENDERNESS 55 0.0053
491 HERNIA 102 0.0053
492 IRRITABILITY 316 0.0052
493 ENERGY INCREASED 31 0.0052
494 ASPARTATE AMINOTRANSFERASE INCREASED 279 0.0052
495 TOOTH DISORDER 116 0.0052
496 TACHYCARDIA 463 0.0052
497 LIMB INJURY 141 0.0052
498 MOUTH ULCERATION 109 0.0052
499 CYST 64 0.0052
500 CYSTITIS 163 0.0051
501 NAIL DISCOLOURATION 20 0.0051
502 MUSCULOSKELETAL DISCOMFORT 87 0.0050
503 PRODUCT QUALITY ISSUE 686 0.0050
504 RENAL PAIN 53 0.0050
505 MUSCLE FATIGUE 21 0.0050
506 THYROID MASS 19 0.0049
507 PAIN OF SKIN 133 0.0049
508 MASS 69 0.0049
509 MAJOR DEPRESSION 36 0.0049
510 DIARRHOEA HAEMORRHAGIC 46 0.0049
511 ANKLE FRACTURE 76 0.0049
512 REHABILITATION THERAPY 19 0.0049
513 CARDIAC VALVE DISEASE 28 0.0049
514 CRYING 176 0.0048
515 FEELING ABNORMAL 1151 0.0048
516 PHOTOSENSITIVITY REACTION 79 0.0048
517 SPINAL OSTEOARTHRITIS 42 0.0048
518 COLON CANCER 71 0.0048
519 SKIN IRRITATION 218 0.0048
520 ABNORMAL DREAMS 131 0.0047
521 ALANINE AMINOTRANSFERASE INCREASED 290 0.0047
522 PRODUCTIVE COUGH 225 0.0047
523 SNEEZING 105 0.0047
524 BRAIN NEOPLASM 43 0.0047
525 LIMB DISCOMFORT 144 0.0046
526 INFLUENZA LIKE ILLNESS 382 0.0046
527 THYROID DISORDER 71 0.0046
528 OROPHARYNGEAL PAIN 425 0.0046
529 LIGAMENT SPRAIN 45 0.0045
530 RENAL DISORDER 212 0.0045
531 DERMATITIS 95 0.0045
532 ADRENAL INSUFFICIENCY 55 0.0045
533 APPETITE DISORDER 30 0.0045
534 PALPITATIONS 528 0.0045
535 NEURALGIA 109 0.0045
536 ORAL CANDIDIASIS 59 0.0045
537 TONGUE DISCOMFORT 19 0.0045
538 ANGER 151 0.0045
539 DYSPNOEA 2519 0.0044
540 ROTATOR CUFF SYNDROME 57 0.0044
541 BURNING SENSATION 311 0.0044
542 STAPHYLOCOCCAL INFECTION 146 0.0044
543 SUNBURN 33 0.0044
544 SKIN LACERATION 48 0.0044
545 SLUGGISHNESS 45 0.0044
546 HEPATIC ENZYME ABNORMAL 22 0.0044
547 SECRETION DISCHARGE 55 0.0044
548 DERMATITIS ALLERGIC 55 0.0044
549 INCORRECT PRODUCT ADMINISTRATION DURATION 94 0.0043
550 NERVE COMPRESSION 40 0.0043
551 RASH ERYTHEMATOUS 207 0.0043
552 URINARY TRACT INFECTION 738 0.0043
553 ERYTHEMA 889 0.0043
554 VIRAL INFECTION 143 0.0043
555 GASTROINTESTINAL MOTILITY DISORDER 23 0.0043
556 ACCIDENT 51 0.0043
557 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 234 0.0043
558 TOOTHACHE 77 0.0042
559 PANIC ATTACK 155 0.0042
560 NERVOUSNESS 221 0.0042
561 POLLAKIURIA 176 0.0042
562 MYALGIA 715 0.0042
563 DRY SKIN 554 0.0041
564 COVID-19 PNEUMONIA 49 0.0041
565 BIPOLAR DISORDER 45 0.0041
566 BLOOD TEST ABNORMAL 58 0.0041
567 HOSPITALISATION 633 0.0041
568 CHOLECYSTECTOMY 47 0.0041
569 PRODUCT PRESCRIBING ERROR 98 0.0041
570 PULMONARY CONGESTION 54 0.0041
571 INITIAL INSOMNIA 42 0.0041
572 INTERVERTEBRAL DISC PROTRUSION 89 0.0041
573 NODULE 53 0.0041
574 HEPATITIS C 49 0.0041
575 DIABETES MELLITUS 308 0.0040
576 PYELONEPHRITIS 35 0.0040
577 TREMOR 667 0.0040
578 HYPERKERATOSIS 22 0.0040
579 GASTROINTESTINAL INFLAMMATION 31 0.0040
580 HAND FRACTURE 28 0.0039
581 GASTRIC ULCER 75 0.0039
582 MUSCULOSKELETAL CHEST PAIN 61 0.0039
583 FEELING OF BODY TEMPERATURE CHANGE 23 0.0039
584 LEUKAEMIA 37 0.0039
585 WRIST FRACTURE 47 0.0039
586 PAIN IN JAW 111 0.0039
587 SKIN MASS 26 0.0039
588 TREATMENT NONCOMPLIANCE 213 0.0039
589 TENDON RUPTURE 48 0.0039
590 FACIAL PARALYSIS 33 0.0039
591 FALL 1288 0.0039
592 FEELING OF DESPAIR 18 0.0039
593 DERMATITIS CONTACT 44 0.0039
594 MYASTHENIA GRAVIS 31 0.0038
595 CARDIAC DISORDER 357 0.0038
596 POST PROCEDURAL INFECTION 31 0.0038
597 BACTERIAL INFECTION 71 0.0038
598 HEART RATE INCREASED 376 0.0038
599 VITAMIN D DEFICIENCY 37 0.0038
600 BLOOD IRON DECREASED 45 0.0038
601 LYMPHADENOPATHY 134 0.0038
602 ORAL PAIN 84 0.0037
603 PRURITUS GENERALISED 81 0.0037
604 ECZEMA 196 0.0037
605 DISEASE RECURRENCE 178 0.0037
606 AUTOIMMUNE HEPATITIS 26 0.0037
607 HYPERCHLORHYDRIA 22 0.0037
608 HIDRADENITIS 34 0.0037
609 BLADDER DISORDER 37 0.0037
610 PELVIC FRACTURE 29 0.0037
611 RHINITIS 30 0.0037
612 NIGHTMARE 128 0.0037
613 HYSTERECTOMY 32 0.0037
614 HAEMORRHOIDAL HAEMORRHAGE 18 0.0037
615 BODY TEMPERATURE INCREASED 75 0.0037
616 CATARACT 218 0.0037
617 NONSPECIFIC REACTION 20 0.0036
618 NEPHROPATHY 34 0.0036
619 BLOOD PRESSURE INCREASED 555 0.0036
620 DEAFNESS UNILATERAL 20 0.0036
621 UTERINE CANCER 29 0.0036
622 CONJUNCTIVITIS 67 0.0036
623 STENT PLACEMENT 29 0.0036
624 FRUSTRATION TOLERANCE DECREASED 29 0.0036
625 HAEMORRHOIDS 70 0.0036
626 TINNITUS 164 0.0036
627 GASTRITIS 93 0.0035
628 APPENDICITIS 33 0.0035
629 RASH PAPULAR 79 0.0035
630 HAEMATOCHEZIA 194 0.0035
631 POLYP 23 0.0035
632 DYSSTASIA 102 0.0035
633 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
634 RESPIRATION ABNORMAL 24 0.0035
635 APHTHOUS ULCER 27 0.0035
636 LYMPHOEDEMA 24 0.0035
637 COLD SWEAT 61 0.0035
638 MUSCLE DISORDER 28 0.0035
639 PROSTATIC DISORDER 19 0.0034
640 EMOTIONAL DISORDER 106 0.0034
641 HYPOACUSIS 148 0.0034
642 VITAMIN D DECREASED 29 0.0034
643 LETHARGY 195 0.0034
644 THINKING ABNORMAL 63 0.0034
645 COMPRESSION FRACTURE 18 0.0034
646 CARDIAC PACEMAKER INSERTION 20 0.0034
647 DRY THROAT 34 0.0033
648 MUSCLE TIGHTNESS 54 0.0033
649 TENSION 20 0.0033
650 SKIN BURNING SENSATION 234 0.0033
651 SKIN HYPERPIGMENTATION 28 0.0033
652 RIB FRACTURE 67 0.0033
653 APHONIA 45 0.0032
654 ANGIOPATHY 18 0.0032
655 SENSATION OF FOREIGN BODY 27 0.0032
656 ASPIRATION 35 0.0032
657 BREAST TENDERNESS 24 0.0032
658 BONE DISORDER 58 0.0032
659 HEPATITIS B 19 0.0031
660 POST-TRAUMATIC STRESS DISORDER 21 0.0031
661 HERPES VIRUS INFECTION 18 0.0031
662 SKIN SWELLING 27 0.0031
663 TEMPERATURE INTOLERANCE 32 0.0031
664 SPINAL FRACTURE 62 0.0031
665 FLANK PAIN 29 0.0031
666 BONE PAIN 181 0.0031
667 APATHY 45 0.0031
668 PHOTOPHOBIA 58 0.0031
669 INSURANCE ISSUE 47 0.0031
670 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 90 0.0031
671 HYPERSOMNIA 88 0.0031
672 EXPIRED PRODUCT ADMINISTERED 102 0.0031
673 MICTURITION URGENCY 35 0.0031
674 BLOOD CREATININE INCREASED 200 0.0031
675 VERTIGO 186 0.0030
676 RETINAL DETACHMENT 28 0.0030
677 HYPERAESTHESIA 25 0.0030
678 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 548 0.0030
679 CATARACT OPERATION 18 0.0030
680 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 158 0.0030
681 SWELLING OF EYELID 19 0.0030
682 LUNG NEOPLASM MALIGNANT 124 0.0030
683 EATING DISORDER 64 0.0030
684 ABDOMINAL PAIN LOWER 76 0.0030
685 MIDDLE INSOMNIA 56 0.0030
686 HYPERHIDROSIS 386 0.0030
687 THERAPEUTIC RESPONSE SHORTENED 99 0.0030
688 SENSORY LOSS 24 0.0030
689 LACERATION 28 0.0030
690 MENTAL DISORDER 129 0.0030
691 CARDIAC FLUTTER 19 0.0029
692 HERPES SIMPLEX 19 0.0029
693 DYSGEUSIA 217 0.0029
694 FACIAL PAIN 26 0.0029
695 BREAST PAIN 31 0.0029
696 DYSURIA 107 0.0029
697 RENAL IMPAIRMENT 244 0.0029
698 NASAL DISCOMFORT 23 0.0029
699 HAIR GROWTH ABNORMAL 20 0.0029
700 CONSTIPATION 630 0.0029
701 FORMICATION 20 0.0029
702 INTERCEPTED PRODUCT ADMINISTRATION ERROR 22 0.0029
703 BLOOD PRESSURE ABNORMAL 57 0.0029
704 THIRST 51 0.0029
705 BREAST MASS 19 0.0028
706 OVARIAN CANCER 26 0.0028
707 IRON DEFICIENCY ANAEMIA 26 0.0028
708 ATRIAL FIBRILLATION 273 0.0028
709 ABNORMAL LOSS OF WEIGHT 19 0.0028
710 DYSPHONIA 161 0.0028
711 BLOOD URINE PRESENT 52 0.0027
712 EYE DISORDER 90 0.0027
713 FOOD ALLERGY 21 0.0027
714 HOT FLUSH 205 0.0027
715 CLOSTRIDIUM DIFFICILE INFECTION 59 0.0027
716 THERAPEUTIC RESPONSE UNEXPECTED 121 0.0027
717 PRODUCT DISTRIBUTION ISSUE 25 0.0027
718 ABSCESS 43 0.0027
719 PULMONARY MASS 40 0.0027
720 DEHYDRATION 355 0.0027
721 PHARYNGITIS 33 0.0027
722 ANGINA PECTORIS 76 0.0026
723 DRY EYE 132 0.0026
724 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
725 GINGIVAL PAIN 21 0.0026
726 SPUTUM DISCOLOURED 25 0.0026
727 GROIN PAIN 23 0.0026
728 CHEST DISCOMFORT 268 0.0026
729 HAEMATEMESIS 66 0.0026
730 LUNG INFECTION 40 0.0026
731 CEREBRAL DISORDER 19 0.0026
732 TRANSIENT ISCHAEMIC ATTACK 86 0.0025
733 OROPHARYNGEAL DISCOMFORT 23 0.0025
734 FRACTURE 48 0.0025
735 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
736 CHILLS 296 0.0025
737 BREAST CANCER 235 0.0025
738 CANDIDA INFECTION 42 0.0025
739 CHROMATURIA 56 0.0025
740 COLITIS 94 0.0025
741 RESTLESS LEGS SYNDROME 45 0.0025
742 FOETAL EXPOSURE DURING PREGNANCY 201 0.0025
743 HIATUS HERNIA 32 0.0025
744 HYPOPHAGIA 63 0.0025
745 MOVEMENT DISORDER 79 0.0025
746 INCREASED APPETITE 47 0.0025
747 MUSCLE ATROPHY 31 0.0024
748 MENORRHAGIA 48 0.0024
749 GLAUCOMA 47 0.0024
750 NERVE INJURY 27 0.0024
751 EYE SWELLING 90 0.0024
752 VASCULITIS 28 0.0024
753 PRODUCT DISPENSING ERROR 52 0.0024
754 BLOOD GLUCOSE ABNORMAL 44 0.0024
755 LEUKOPENIA 119 0.0024
756 CHOLELITHIASIS 78 0.0024
757 OSTEOPENIA 36 0.0024
758 FACE OEDEMA 40 0.0024
759 AGEUSIA 59 0.0024
760 INTERNAL HAEMORRHAGE 27 0.0024
761 THROAT IRRITATION 106 0.0024
762 BEDRIDDEN 31 0.0024
763 NEOPLASM 27 0.0023
764 ARTERIOSCLEROSIS 22 0.0023
765 HIP FRACTURE 75 0.0023
766 THYROID CANCER 28 0.0023
767 SWELLING FACE 150 0.0023
768 HEART RATE IRREGULAR 52 0.0023
769 SALIVARY HYPERSECRETION 23 0.0023
770 INCORRECT DOSE ADMINISTERED 524 0.0023
771 ARTERIAL OCCLUSIVE DISEASE 18 0.0023
772 LIP SWELLING 76 0.0023
773 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 76 0.0022
774 CEREBROVASCULAR ACCIDENT 376 0.0022
775 SENSORY DISTURBANCE 35 0.0022
776 PNEUMONIA BACTERIAL 20 0.0022
777 TOOTH FRACTURE 24 0.0022
778 BONE DENSITY DECREASED 68 0.0022
779 TOOTH EXTRACTION 27 0.0022
780 MYOCARDIAL INFARCTION 375 0.0021
781 PHARYNGEAL OEDEMA 33 0.0021
782 ACNE 160 0.0021
783 PULMONARY THROMBOSIS 23 0.0021
784 EYE HAEMORRHAGE 28 0.0021
785 DERMATITIS ATOPIC 110 0.0021
786 LACRIMATION INCREASED 63 0.0021
787 SEPSIS 230 0.0021
788 GASTROENTERITIS 30 0.0021
789 IMPAIRED GASTRIC EMPTYING 28 0.0021
790 PHARYNGEAL SWELLING 20 0.0020
791 HEPATOMEGALY 20 0.0020
792 DEAFNESS 53 0.0020
793 BLOOD PRESSURE DECREASED 134 0.0020
794 HAEMOPTYSIS 56 0.0020
795 EPISTAXIS 149 0.0020
796 HYPOAESTHESIA ORAL 30 0.0020
797 BLOOD TRIGLYCERIDES INCREASED 35 0.0020
798 ANAPHYLACTIC SHOCK 51 0.0020
799 DEMENTIA 55 0.0020
800 OCULAR DISCOMFORT 22 0.0020
801 NEUTROPHIL COUNT INCREASED 20 0.0020
802 SWOLLEN TONGUE 61 0.0020
803 BRAIN FOG 30 0.0019
804 GLYCOSYLATED HAEMOGLOBIN INCREASED 48 0.0019
805 BLOOD POTASSIUM DECREASED 57 0.0019
806 BLOOD GLUCOSE DECREASED 91 0.0019
807 PNEUMOTHORAX 30 0.0019
808 DISTURBANCE IN ATTENTION 102 0.0019
809 CARDIAC FAILURE CONGESTIVE 151 0.0019
810 BODY HEIGHT DECREASED 20 0.0019
811 DEATH 1608 0.0019
812 THROMBOSIS 150 0.0019
813 HEAD INJURY 59 0.0019
814 CHOLECYSTITIS 22 0.0018
815 MUCOSAL INFLAMMATION 48 0.0018
816 EYE DISCHARGE 19 0.0018
817 SOMNOLENCE 365 0.0018
818 ANGIOEDEMA 80 0.0018
819 FEELING COLD 50 0.0018
820 BRAIN INJURY 18 0.0018
821 DYSPHAGIA 170 0.0018
822 SLEEP APNOEA SYNDROME 34 0.0018
823 GINGIVAL BLEEDING 24 0.0018
824 MULTIPLE SCLEROSIS 84 0.0018
825 PERIPHERAL COLDNESS 24 0.0017
826 NEUROPATHY PERIPHERAL 166 0.0017
827 HYPOTHYROIDISM 55 0.0017
828 THROMBOCYTOPENIA 192 0.0017
829 TRANSAMINASES INCREASED 38 0.0017
830 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
831 BLOOD PRESSURE FLUCTUATION 41 0.0017
832 GENERALISED OEDEMA 21 0.0017
833 SCAR 29 0.0017
834 ACCIDENTAL OVERDOSE 61 0.0017
835 POST PROCEDURAL COMPLICATION 32 0.0017
836 NOCTURIA 20 0.0016
837 LOSS OF CONSCIOUSNESS 211 0.0016
838 DENTAL CARIES 18 0.0016
839 OVERDOSE 351 0.0016
840 ARRHYTHMIA 77 0.0016
841 PRESYNCOPE 39 0.0016
842 ABORTION SPONTANEOUS 64 0.0016
843 AGITATION 117 0.0016
844 PROSTATE CANCER 128 0.0016
845 PRODUCT DOSE OMISSION IN ERROR 45 0.0016
846 HYPERTHYROIDISM 23 0.0016
847 FULL BLOOD COUNT DECREASED 32 0.0016
848 ORAL DISCOMFORT 22 0.0016
849 HUNGER 22 0.0016
850 SEIZURE 182 0.0016
851 INTRAOCULAR PRESSURE INCREASED 20 0.0016
852 OCULAR HYPERAEMIA 74 0.0016
853 HAEMORRHAGE 163 0.0016
854 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 110 0.0015
855 BLINDNESS 63 0.0015
856 CARDIAC FAILURE 124 0.0015
857 BLOOD POTASSIUM INCREASED 25 0.0015
858 PARALYSIS 22 0.0015
859 BLOOD GLUCOSE INCREASED 287 0.0015
860 BACTERAEMIA 18 0.0015
861 PSYCHOMOTOR HYPERACTIVITY 25 0.0015
862 BLINDNESS UNILATERAL 21 0.0015
863 RENAL FAILURE 197 0.0015
864 HEART RATE DECREASED 52 0.0015
865 MENSTRUATION IRREGULAR 39 0.0015
866 FEMUR FRACTURE 45 0.0015
867 PARANOIA 25 0.0014
868 RESTLESSNESS 53 0.0014
869 DEVICE RELATED INFECTION 22 0.0014
870 DIPLOPIA 37 0.0014
871 SYNCOPE 142 0.0014
872 INTESTINAL OBSTRUCTION 53 0.0014
873 THROAT TIGHTNESS 38 0.0014
874 DISORIENTATION 55 0.0014
875 CORONARY ARTERY OCCLUSION 19 0.0014
876 EYE PAIN 78 0.0014
877 ANOSMIA 20 0.0014
878 NERVOUS SYSTEM DISORDER 43 0.0014
879 PRODUCT PRESCRIBING ISSUE 30 0.0014
880 EXTRA DOSE ADMINISTERED 55 0.0014
881 MUSCLE TWITCHING 31 0.0013
882 LYMPHOPENIA 19 0.0013
883 BALANCE DISORDER 116 0.0013
884 DYSPNOEA EXERTIONAL 50 0.0013
885 BLOOD SODIUM DECREASED 25 0.0013
886 EYE PRURITUS 44 0.0013
887 LIVER FUNCTION TEST ABNORMAL 38 0.0013
888 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
889 BRONCHOSPASM 18 0.0013
890 INTERSTITIAL LUNG DISEASE 61 0.0013
891 VISION BLURRED 171 0.0012
892 GASTROINTESTINAL HAEMORRHAGE 104 0.0012
893 HYPOKINESIA 18 0.0012
894 HYPOKALAEMIA 57 0.0012
895 VAGINAL HAEMORRHAGE 53 0.0012
896 BREAST CANCER FEMALE 32 0.0012
897 PROCEDURAL PAIN 33 0.0012
898 PRODUCT STORAGE ERROR 104 0.0012
899 DEEP VEIN THROMBOSIS 77 0.0012
900 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 240 0.0012
901 ANAPHYLACTIC REACTION 64 0.0012
902 SUICIDE ATTEMPT 70 0.0012
903 BLADDER CANCER 67 0.0011
904 DRUG ADMINISTRATION ERROR 34 0.0011
905 ABASIA 27 0.0011
906 DRUG RESISTANCE 28 0.0011
907 CORONARY ARTERY DISEASE 33 0.0011
908 HEPATIC CANCER 26 0.0011
909 HAEMATURIA 37 0.0011
910 HEPATOTOXICITY 24 0.0011
911 MENTAL IMPAIRMENT 26 0.0011
912 FLUSHING 109 0.0011
913 PNEUMONITIS 29 0.0011
914 CARDIOVASCULAR DISORDER 27 0.0011
915 WHITE BLOOD CELL COUNT DECREASED 115 0.0011
916 SEPTIC SHOCK 46 0.0011
917 URINARY RETENTION 35 0.0010
918 SPEECH DISORDER 54 0.0010
919 ANAEMIA 196 0.0010
920 ERECTILE DYSFUNCTION 26 0.0010
921 CEREBRAL HAEMORRHAGE 36 0.0010
922 PANCREATIC CARCINOMA 29 0.0010
923 HALLUCINATION 75 0.0010
924 HEPATIC FAILURE 30 0.0010
925 HEPATIC FUNCTION ABNORMAL 37 0.0010
926 PULMONARY OEDEMA 44 0.0010
927 RED BLOOD CELL COUNT DECREASED 28 0.0010
928 CHOKING 19 0.0010
929 PULMONARY EMBOLISM 91 0.0010
930 HYPOGLYCAEMIA 46 0.0009
931 STEVENS-JOHNSON SYNDROME 21 0.0009
932 RASH MACULO-PAPULAR 21 0.0009
933 INJECTION SITE BRUISING 74 0.0009
934 DISEASE PROGRESSION 109 0.0009
935 PALLOR 25 0.0009
936 ACUTE MYOCARDIAL INFARCTION 27 0.0009
937 MENTAL STATUS CHANGES 25 0.0009
938 EYE IRRITATION 51 0.0009
939 PSYCHOTIC DISORDER 26 0.0009
940 AGGRESSION 44 0.0009
941 HAEMOGLOBIN DECREASED 88 0.0009
942 COGNITIVE DISORDER 40 0.0009
943 OESOPHAGEAL CARCINOMA 25 0.0008
944 HYPOTENSION 169 0.0008
945 WITHDRAWAL SYNDROME 35 0.0008
946 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
947 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
948 EMOTIONAL DISTRESS 97 0.0008
949 HYPERGLYCAEMIA 29 0.0008
950 HAEMATOMA 20 0.0008
951 INJECTION SITE PAIN 231 0.0008
952 NO ADVERSE EVENT 136 0.0007
953 CHRONIC KIDNEY DISEASE 56 0.0007
954 CEREBRAL INFARCTION 18 0.0007
955 INJECTION SITE URTICARIA 18 0.0007
956 APHASIA 22 0.0007
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34 0.0007
958 DEVICE MALFUNCTION 51 0.0007
959 DRUG INTERACTION 115 0.0007
960 INJECTION SITE PRURITUS 48 0.0007
961 RENAL CANCER 34 0.0007
962 INJECTION SITE RASH 21 0.0007
963 URINARY INCONTINENCE 20 0.0007
964 INJECTION SITE HAEMORRHAGE 52 0.0007
965 PANCYTOPENIA 36 0.0006
966 RESPIRATORY FAILURE 46 0.0006
967 OSTEONECROSIS 20 0.0006
968 ABNORMAL BEHAVIOUR 24 0.0006
969 MULTIPLE SCLEROSIS RELAPSE 40 0.0006
970 PLEURAL EFFUSION 35 0.0006
971 DEVICE ISSUE 51 0.0006
972 COMA 27 0.0006
973 INJECTION SITE SWELLING 43 0.0006
974 DYSARTHRIA 21 0.0006
975 PLATELET COUNT DECREASED 57 0.0005
976 OXYGEN SATURATION DECREASED 30 0.0005
977 HYPOXIA 18 0.0005
978 INJECTION SITE ERYTHEMA 62 0.0005
979 INJECTION SITE MASS 18 0.0005
980 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
981 ACUTE KIDNEY INJURY 64 0.0004
982 CARDIAC ARREST 32 0.0004
983 COMPLETED SUICIDE 29 0.0003
984 BRADYCARDIA 18 0.0003
985 DEVICE DIFFICULT TO USE 21 0.0003
986 TOXICITY TO VARIOUS AGENTS 40 0.0002
987 NEUTROPENIA 24 0.0002